IMMUNOLOGICAL COMPLEXITY AND SEPSIS-RELATED GRAFT DYSFUNCTION IN A PEDIATRIC KIDNEY TRANSPLANT RECIPIENT: A CASE-BASED REVIEW
DOI:
https://doi.org/10.30888/2663-5712.2025-33-02-031Keywords:
Pediatric renal transplantation, sepsis, immunosuppression. EBV pseudopositivity, ANA positivity.Abstract
Pediatric kidney transplantation is a definitive therapeutic intervention for end-stage renal disease, significantly improving both survival and quality of life. However, the procedure comes with unique challenges, primarily due to a child's still-developReferences
Winterberg P. D., Garro R. Long-Term Outcomes of Kidney Transplantation in Children. Pediatric Clinics of North America. 2019. Vol. 66, № 1. P. 269–280. DOI: 10.1016/j.pcl.2018.09.008.
Danziger-Isakov L., Kumar D. Vaccination in solid organ transplantation. American Journal of Transplantation. 2013. Vol. 13. Suppl. 4. P. 311–317. DOI: 10.1111/ajt.12122.
Hariharan S. et al. Long-term Kidney Transplant Survival Across the Globe. Transplantation. 2024. Vol. 108, № 9. P. e254–e263. DOI: 10.1097/TP.0000000000004977.
Zhang Y. et al. Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis. Frontiers in Pediatrics. 2023. Vol. 11. Art. 1060053. DOI: 10.3389/fped.2023.1060053.
Martins M. E. C. C. et al. Detection of the Presence of Epstein−Barr Virus and Cytomegalovirus Using Polymerase Chain Reaction in Patients With Chronic Kidney Disease. Journal of Oral Diagnosis. 2023. Vol. 8. P. 1–7. DOI: 10.5935/2525-5711.20230220.
Hatton O. L. et al. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease. Immunology Research. 2014. Vol. 58, № 2–3. P. 268–276. DOI: 10.1007/s12026-014-8496-1.
Yang X., Lin B., Shen T. Clinical features of renal damage associated with Epstein-Barr virus infection in children. Frontiers in Pediatrics. 2023. Vol. 11. Art. 1123941. DOI: 10.3389/fped.2023.1123941.
Roger S. D. et al. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study. Nephrology Dialysis Transplantation. 2021. Vol. 36, № 1. P. 137–150. DOI: 10.1093/ndt/gfz285.
Luderer R. et al. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation. Molecular Diagnosis. 2005. Vol. 9, № 4. P. 195–200. DOI: 10.1007/BF03260091.
Mejdoub S. et al. Antinuclear antibodies in children: clinical signification and diagnosis utility. La Tunisie medicale. 2021. Vol. 99, № 10. P. 980–984. PMID: 35288899.
Schachtner T., Stein M., Reinke P. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors. Transplant Infectious Disease. 2017. Vol. 19, № 3. DOI: 10.1111/tid.12695.
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Transplantation. 2009. Vol. 9. Suppl. 3. P. S1–S155. DOI: 10.1111/j.1600-6143.2009.02834.x.
Indian Society of Organ Transplantation (ISOT). Pediatric transplant protocols. URL: https://notto.mohfw.gov.in/WriteReadData/Portal/News/858_1_Updated_NOTTO_ANNUAL_REPORT__08-05-24_.pdf (дата звернення: 09.09.2025).
Oomen L. et al. Pediatric kidney transplantation in Europe, a clinical snapshot pilot. Frontiers in Pediatrics. 2024. Vol. 12. Art. 1432027. DOI: 10.3389/fped.2024.1432027.
MacDonald N. et al. Global vaccine action plan lessons learned I: Recommendations for the next decade. Vaccine. 2020. Vol. 38, № 33. P. 5364–5371. DOI: 10.1016/j.vaccine.2020.05.003.
Moore D. L. Immunization of the immunocompromised child: Key principles. Paediatr Child Health. 2018. Vol. 23, № 3. P. 203–205. DOI: 10.1093/pch/pxx180.
Casotti V. et al. Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients. Vaccines (Basel). 2024. Vol. 12, № 9. Art. 952. DOI: 10.3390/vaccines12090952.
Park S. et al. European Society of Organ Transplantation Consensus Statement on Testing for Non-Invasive Diagnosis of Kidney Allograft Rejection. Transplantation International. 2024. Vol. 36. Art. 12115. DOI: 10.3389/ti.2023.12115.
Furian L. et al. European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study. Transplantation International. 2024. Vol. 37. Art. 12475. DOI: 10.3389/ti.2024.12475.
Bafi A. T., Tomotani D. Y., de Freitas F. G. Sepsis in Solid-Organ Transplant Patients. Shock. 2017. Vol. 47. Suppl. 1. P. 12–16. DOI: 10.1097/SHK.0000000000000700.
Bolaños-Meade J. et al. Three prophylaxis regimens (...) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). Lancet Haematology. 2019. Vol.6, №3. P.e132–e143. DOI:10.1016/S2352-3026(18)30221-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
